This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical: Archive
Buy UnitedHealth or Humana Stock as Medicare Advantage Rates Increase?
by Shaun Pruitt
A much larger-than-expected increase in Medicare Advantage payment rates triggered a broad relief rally across health insurer stocks on Monday, with UnitedHealth and Humana leading the way.
UNHPositive Net Change HUMPositive Net Change
dividend-investing dividends earnings hmo insurance investing medical
Top Research Reports for AstraZeneca, HSBC & Walt Disney
by Mark Vickery
AstraZeneca's strong drug portfolio and pipeline fuel growth targets, while HSBC restructures and Disney balances streaming gains against rising costs.
AZNNegative Net Change DUKPositive Net Change STXPositive Net Change DISNegative Net Change NXPINegative Net Change HSBCPositive Net Change OVLYNegative Net Change BVFLPositive Net Change
consumer-discretionary finance medical
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
by Zacks Equity Research
STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud connectivity to boost workflow, precision and digital surgery.
STXSNegative Net Change GMEDPositive Net Change PACBPositive Net Change BDSXNegative Net Change
medical medical-devices
Denali Stock Falls as Partner Takeda Ends Collaboration Deal
by Zacks Equity Research
DNLI's shares decline after Takeda exits DNL593 partnership, leaving Denali to fully control and fund the therapy as it advances studies and plans 2026 data release.
SNYNegative Net Change BIIBPositive Net Change DNLIPositive Net Change TAKPositive Net Change
biotechnology biotechs medical pharmaceuticals
What's Driving TEM Data and Applications Arm's Robust Growth?
by Sridatri Sarkar
Tempus AI's data arm surges with 69.5% Insights growth, $1.1B+ contracts, and AI-driven expansion fueling strong revenue outlook and customer retention gains.
ICLRNegative Net Change SOPHNegative Net Change TEMNegative Net Change
medical
5 Low-Leverage Stocks to Buy as Investors Hope for Truce
by Aparajita Dutta
Low-leverage stocks like PNTG gain appeal as investors seek stability amid geopolitical tensions, with strong earnings growth and strategic moves boosting outlook.
RYPositive Net Change STNNegative Net Change CASYNegative Net Change PNTGPositive Net Change VLTOPositive Net Change
business-services finance medical
PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch
by Zacks Equity Research
PAVmed taps industry veteran Joseph Virgilio to lead its device portfolio relaunch to boost growth, commercialization and long-term shareholder value.
CAHPositive Net Change PAHCPositive Net Change PAVMNegative Net Change GEHCNegative Net Change
medical medical-devices
UnitedHealth Jumps on CMS' MA Rate Boost: How to Position Now
by Kaibalya Pravo Dey
CMS boosts 2027 Medicare Advantage rates, sparking a sharp UNH rally despite lingering cost pressures.
UNHPositive Net Change HUMPositive Net Change CNCPositive Net Change
healthcare hmo insurance medical
Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?
by Zacks Equity Research
Investors need to pay close attention to ALNY stock based on the movements in the options market lately.
ALNYNegative Net Change
medical
Implied Volatility Surging for Delcath Systems Stock Options
by Zacks Equity Research
Investors need to pay close attention to DCTH stock based on the movements in the options market lately.
DCTHNegative Net Change
medical